Search Results - "Samadfam, R"

Refine Results
  1. 1

    Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys by Duong, L.T, Pickarski, M, Cusick, T, Chen, C.M, Zhuo, Y, Scott, K, Samadfam, R, Smith, S.Y, Pennypacker, B.L

    Published in Bone (New York, N.Y.) (01-07-2016)
    “…Abstract The objectives here were to evaluate the effects of odanacatib (ODN) at doses exceeding the clinical exposure on biomechanical properties of lumbar…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Contribution of B2 receptors for bradykinin in Arthus reaction‐induced plasma extravasation in wild‐type or B2 transgenic knockout mice by Samadfam, R, Teixeira, C, Bkaily, G, Sirois, P, De Brum‐Fernandes, A, D'Orleans‐Juste, P

    Published in British journal of pharmacology (01-04-2000)
    “…The aim of the present study was to investigate the contribution of bradykinin (BK) B1 and B2 receptors in a model of type III hypersensitivity, the reverse…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Effects of Denosumab, Alendronate, or Denosumab Following Alendronate on Bone Turnover, Calcium Homeostasis, Bone Mass and Bone Strength in Ovariectomized Cynomolgus Monkeys by Kostenuik, Paul J, Smith, Susan Y, Samadfam, Rana, Jolette, Jacquelin, Zhou, Lei, Ominsky, Michael S

    Published in Journal of bone and mineral research (01-04-2015)
    “…ABSTRACT Postmenopausal osteoporosis is a chronic disease wherein increased bone remodeling reduces bone mass and bone strength. Antiresorptive agents…”
    Get full text
    Journal Article
  13. 13

    Co‐Treatment of PTH With Osteoprotegerin or Alendronate Increases Its Anabolic Effect on the Skeleton of Oophorectomized Mice by Samadfam, Rana, Xia, Qingwen, Goltzman, David

    Published in Journal of bone and mineral research (01-01-2007)
    “…We examined the effects of 60 days of co‐treatment of PTH with either OPG or alendronate in oophorectomized mice. Compared with PTH alone, co‐treatment of PTH…”
    Get full text
    Journal Article
  14. 14

    Cathepsin K inhibitors prevent bone loss in estrogen‐deficient rabbits by Pennypacker, Brenda L, Duong, Le T, Cusick, Tara E, Masarachia, Patricia J, Gentile, Michael A, Gauthier, Jacques‐Yves, Black, W Cameron, Scott, Boyd B, Samadfam, Rana, Smith, Susan Y, Kimmel, Donald B

    Published in Journal of bone and mineral research (01-02-2011)
    “…Two cathepsin K inhibitors (CatKIs) were compared with alendronate (ALN) for their effects on bone resorption and formation in ovariectomized (OVX) rabbits…”
    Get full text
    Journal Article
  15. 15

    The Effect of Rosiglitazone on Bone Mass and Fragility Is Reversible and Can Be Attenuated With Alendronate by Kumar, Sanjay, Hoffman, Sandra J, Samadfam, Rana, Mansell, Peter, Jolette, Jacquelin, Smith, Susan Y, Guldberg, Robert E, Fitzpatrick, Lorraine A

    Published in Journal of bone and mineral research (01-07-2013)
    “…ABSTRACT Rosiglitazone (RSG) is an antidiabetic drug that has been associated with increased peripheral fractures, primarily in postmenopausal women. In this…”
    Get full text
    Journal Article
  16. 16

    The calcium‐sensing receptor and 25‐hydroxyvitamin D–1α‐hydroxylase interact to modulate skeletal growth and bone turnover by Richard, Christian, Huo, Rujuan, Samadfam, Rana, Bolivar, Isabel, Miao, Dengshun, Brown, Edward M, Hendy, Geoffrey N, Goltzman, David

    Published in Journal of bone and mineral research (01-07-2010)
    “…We examined parathyroid and skeletal function in 3‐month‐old mice expressing the null mutation for 25‐hydroxyvitamin D–1α‐hydroxylase [1α(OH)ase−/−] and in…”
    Get full text
    Journal Article
  17. 17

    Contribution of B 2 receptors for bradykinin in Arthus reaction‐induced plasma extravasation in wild‐type or B 2 transgenic knockout mice by Samadfam, R, Teixeira, C, Bkaily, G, Sirois, P, De Brum‐Fernandes, A, D'Orleans‐Juste, P

    Published in British journal of pharmacology (30-01-2009)
    “…The aim of the present study was to investigate the contribution of bradykinin (BK) B 1 and B 2 receptors in a model of type III hypersensitivity, the reverse…”
    Get full text
    Journal Article
  18. 18

    Production of Prostaglandin D2 by Human Osteoblasts and Modulation of Osteoprotegerin, RANKL, and Cellular Migration by DP and CRTH2 Receptors by Gallant, Maxime A, Samadfam, Rana, Hackett, Josette A, Antoniou, John, Parent, Jean‐Luc, de Brum‐Fernandes, Artur J

    Published in Journal of bone and mineral research (01-04-2005)
    “…Human osteoblasts produce PGD2, which acts on the DP receptor to decrease osteoprotegerin production and on the CRTH2 receptor to decrease RANKL expression and…”
    Get full text
    Journal Article
  19. 19

    Exogenous PTH and Endogenous 1,25‐Dihydroxyvitamin D Are Complementary in Inducing an Anabolic Effect on Bone by Samadfam, Rana, Xia, Qingwen, Miao, Dengshun, Hendy, Geoffrey N, Goltzman, David

    Published in Journal of bone and mineral research (01-08-2008)
    “…PTH and 1,25(OH)2D each exert dual anabolic and catabolic skeletal effects. We assessed the potential interaction of PTH and 1,25(OH)2D in promoting skeletal…”
    Get full text
    Journal Article
  20. 20